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| INTRODUCTION
Beside clinical symptoms, the diagnosis of antiphospholipid syndrome (APS) is based on the presence of persistent antiphospholipid antibodies (aPL). The three main cornerstone antibodies are anticardiolipin (aCL) IgM/IgG, anti-beta-2 glycoprotein 1 antibodies (aβ2GPI) IgM/IgG, and lupus anticoagulant (LAC). Among many challenges in aPL measurement, the pre-analytical conditions may influence test results.
1,2 Following the Standardization subcommittee (SSC) of the international society of thrombosis and haemostasis (ISTH) recommendations, FTC should be avoided for all aPL. 3, 4 In contrast to the effect of freeze-thawing in phospholipid-dependent clotting assays used for LAC, there is little scientific literature for solid phase assays (SPA). 5 However, APL testing is mainly performed in batch due to the potential negative influence of pre-analytical variables, such as repeated FTC, on test results.
Evaluating the effect of repeated FTC on aCL IgM/IgG and aβ2GPI
IgM/IgG could generate practical benefits for routine testing. Another useful application could be the use of stored samples for research and method evaluations.
| METHODS
Patient plasmas (n = 42) were selected based on routine results to cover a wide titer range for all four APL, and on availability of an unthawed aliquot (Table 1) .
Citrated plasma was frozen after double centrifugation. 
| RESULTS AND DISCUSSION
To exclude long term storage as a potential source of degradation, all aPL titers after one FTC were compared with the original results (initially also obtained after one FTC). No significant differences between these results were observed. An interesting feature of these results, knowing that some of these samples were already stored for 5 years, is the stability over time. Having a closer look at samples stored frozen for more than 2 years, no significant difference was seen between the initial results and the results after one FTC in the current study. The sample results, 8 for aCL IgG, aCL IgM aβ2GPI IgM, and 13 for aβ2GPI IgG,
showed an excellent correlation coefficient (0.94-0.99) between the initial results and the result after one FTC obtained in this study. Due to the limited number of samples stored more than three years, no useful statistical analysis could be performed to confirm an even longer stability.
After five FTC, none of the samples degraded from positive to negative and no false positive results were seen. Also, no significant titer changes (defined as > 10%) were seen after five FTC. Between the first and following repeated FTCs a Mann-Withney test was performed for all aPL to look for statistical significant differences in titer (Table 2 ). Even after five FTC none of the aPL tested gave a significant difference in results. A correlation between the titers was calculated and illustrated in Figure 2 , showing graphically and mathematical, the good correlation for all four aPL with a CCC between 0.98 and 1.
Considering the high CCC, we could exclude a significant interrun variability as potential influencing factor on variability of titers.
For each sample, a coefficient of variation (CV) was calculated using the test result after each FTC. Comparing the median CV value (for each aPL divided in four categories as described in Table 1) aPL are very heterogeneous group of antibodies. The small sample size, although covering a broad titer range, may be seen as a limitation of this study. Also, all tests were performed using one and the same analytical platform. Other test systems are known to be less robust suffering from lab to lab variation or high between-run variation. 6, 7 Using this automated system excludes these variables, making it possible to exclusively evaluate the effect of freeze-thaw cycles.
| CONCLUSION
We evaluated the stability of aPL titers after several FTC. aCL and aβ2GPI IgG and IgM, over a broad titer range including samples around the cut-off value, are stable over time and after repeated FTC.
With this study, we excluded this pre-analytical factor as source for variability in aPL titer measured by chemiluminescent assays. 
